US-based Henry Schein has acquired Regional Health Care Group (RHCG), a medical products distribution company that caters to public- and private-sector customers across Australia and New Zealand.
The financial terms of the deal were not disclosed by Henry Schein, which provides office-based dental and medical practitioners with health care products and services.
Regional Health Care Group has been acquired from Maurie and Bernard Stang, who will retain a minority stake in Henry Schein’s dental business in Australia and New Zealand.
Maurie Stang said: “We are very pleased to integrate RHCG with Henry Schein, a company that shares our commitment to excellent service and provides customers with the solutions they need to deliver quality care to their patients.
“It’s extremely gratifying to see the exciting opportunities to accelerate our growth.”
For the 12 months ended 30 June 2022, Regional Health Care Group had sales of $42m.
Henry Schein said that it has been serving the dental markets in Australia and New Zealand since 1998. It has been offering dental professionals in the two countries with a variety of dental products, equipment, and services.
The acquisition of Regional Health Care Group will grow its offering to medical practitioners in the region, said the Nasdaq-listed Henry Schein.
Henry Schein board chairman and CEO Stanley Bergman said: “Together, we will advance our long-standing goal of helping health care professionals operate more efficient practices by providing new solutions and technologies for the ultimate benefit of patients.”
Regional Health Care Group is based in Sydney and has an office in Auckland as well. It offers a range of consumables, pharmaceuticals, and equipment.
Its daily operations are led by general manager Stephen Doorey, who will continue to manage it under the same brand. Doorey will report to Henry Schein’s Australia and New Zealand vice president and managing director Mike Covey.
